(Q43765534)

English

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

phase II clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

peripheral T-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ranjana H. Advani

object named as

Ranjana Advani

5

1 reference

ORCID Public Data File 2021

author name string

Francine M Foss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Nelida Sjak-Shie

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Andre Goy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Eric Jacobsen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Rami Komrokji

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Kelly Pendergrass

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Vanessa Bolejack

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

29 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1373-1379

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742521

21 January 2018

Identifiers

10.3109/10428194.2012.742521

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278639%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43765534&oldid=2103145204"